调节性T细胞的研究进展及临床应用
摘要
人体调节性T细胞(Regulatory T cell,Treg)的主要作用为维持自身免疫耐受,调节机体对病原体和肿瘤的免疫应答,占正常人外周CD4+T细胞的5%~10%,广泛存在于淋巴器官及非淋巴器官中。调节性T细胞数量和功能的降低导致自身免疫耐受消失从而产生自身免疫病,相反,调节性T细胞活性的增加会抑制内源性抗肿瘤反应而导致恶性肿瘤的发生。
出处
《当代医学》
2011年第36期33-35,共3页
Contemporary Medicine
参考文献24
-
1Huehn J,Hamann A.Homing to suppress:address codes for Treg migration[J].Trends Immunol,2005,26(12):632-636.
-
2Wan YY,Flavell RA.Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression[J].Nature,2007,445(7129):766-770.
-
3Williams LM,Rudensky AY.Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3[J].Nat Immunol,2007,8(3):277-284.
-
4Liu W,Putnam AL,Xu-Yu Z,et al.CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells[J].J Exp Med,2006b,203(7):1701-1711.
-
5MiyaraM,Yoshioka Y,KitohA,et al.Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor[J].Immunity,2009,30(6):899-911.
-
6Kiniwa Y,Miyahara Y,Wang HY,et al.CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer[J].Clin Cancer Res,2007,13(23):6947-6958.
-
7Strauss L,Bergmann C,Szczepanski M,et al.A unique subset of CD4+CD25 high foxp3+ T cells secreting interleukin-10 and transforming growth factorbetal mediates suppression in the tumor microenvironment[J].Clin Cancer Res,2007,13(15):4345-4354.
-
8Bopp T,Becker C,Klein M,et al.Cyclic adenosine monophosphate is a key component of regulatory T cell mediatsd suppression[J].Exp Med,2007,204(6):1303-1310.
-
9Misra N,Bayry J,Lacroix-Desmazes S,et al.Cutting edge:human CD4+CD25+T cells restrain the maturation and antigen-presenting function of dendritic cells[J].Immunol,2004,172(8):4676-4680.
-
10Deaglio S,Dwyer KM,Cao W,et al.Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells Mediates immune suppression[J].J Exp Med,2007,204(6):1257-1265.
二级参考文献32
-
1刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:32
-
2Pacholczyk R,graj P,lgnatowicz L.Peptide specificity of thymic selection of CD4^+CD25^+T cell[J].J Immunoi,2002.168(2):613-620.
-
3Fontenot JD,Rudensky AY.A well adapted regulatory contrivance:regulatory T cell development and the forkhead family transcription factors Foxp3[J].Nat Immunol,2005,6(4):331-337.
-
4Hartigan-O'Connor DJ,Poon C,Sinclair E,et al.Human CD4^+ regulatory T cells express lower levels of the IL-7 receptor alpha chain(CD127),allowing consistent identification and sorting of live cells[J].Immunol Methods,2007,319(1-2):41-52.
-
5Li-Song S,Jian W,Ding-Feng S,et al.CD4^+CD25^+CD127^low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression[J].Clin Immunol,2009,13l(1):109-118.
-
6Gacci M,Semi S,Lapini A,et al.Regulatory T cells expression in peripheral blood and tumour infiltrate of patients with renal cell carcinoma:Correlation with prognostic factors[J].Eur Urol Suppl,2008,7(3):99.
-
7Beyer M,Kochanek M,Darabi K,et al.Reduced frequencies and suppressive function of CD4^+ CD25^hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine[J].Blood,2005,106(6):2018-2025.
-
8Mittal S,Marshall NA,Duncan L,et al.Local and systemic induction of CD4^+CD25^+ regulatory T-cell population by non-Hodgkin lymphoma[J].Blood,2008,111(11):5359-5370.
-
9Fattorossi A,Battaglia A,Buzzonetti A,et al.Circulating and thymic CD4^+CD25^+T regulatory cells in myasthenia gravis:effect of immunosuppressive treatment[J].Immunology,2005,116(1):134-141.
-
10Catoregli P,Kiroura H,Roechi R,et al.Autoimmune thyroid diseases.Curr Opin Rheumatol,2007,19:44-48.
共引文献7
-
1刘康香,张增,钟燕,黄秋双,章振林.锁骨颅骨发育不全1个家系2例患者RUNX2基因突变检测报告及文献复习[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(4):232-236. 被引量:2
-
2王明霞,黄建林,罗敏琪,巫世瑶,朱尚玲,彭蔚湘,古洁若.类风湿关节炎患者骨质疏松及其相关因素的初步调查[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(4):253-257. 被引量:10
-
3倪晓艳.类风湿关节炎外周血三种细胞因子检测及临床意义[J].中国医药导刊,2012,14(6):991-991. 被引量:2
-
4李倩.CD_4^+CD_(25)^+调节性T细胞检测在急性白血病检测的临床[J].当代医学,2012,18(27):18-19.
-
5王晓华(综述),孙巍(综述),刘卓刚(审校).CD4+CD25+调节性T细胞在血液病中的研究进展[J].白血病.淋巴瘤,2014,23(4):250-252. 被引量:3
-
6热孜万古丽.乌买尔,米吉提.吾普尔,阿布力米提.局马.调节性T细胞在白癜风与自身免疫性甲状腺疾病发生中的免疫机制[J].中华全科医学,2017,15(8):1415-1418. 被引量:15
-
7曾婷婷,田永建,谭立明,余建林,吴洋,蒋永清,陈娟娟,李华,余乐.类风湿关节炎骨质疏松危险因素分析[J].中国骨质疏松杂志,2019,25(1):74-78. 被引量:31
-
1乔瑞洁.IL—2和IL—12基因插入牛痘病毒的抗肿瘤反应[J].生物制品快讯,2003(3):20-21.
-
2黄慧琴,林建峰,李勇.树突状细胞抗肿瘤应用研究进展[J].福建医药杂志,2005,27(5):166-168.
-
3理由.黑素瘤疫苗可能延长病人生命[J].中华医学信息导报,2003,18(3):13-13.
-
4林英辉.Th17细胞与临床疾病的研究进展[J].实用医学杂志,2011,27(2):328-329. 被引量:3
-
5毛丽伟,倪兵,姜曼,黎万玲,肖宇,吴玉章.PD-L1 mAb的制备、鉴定及其特性的研究[J].免疫学杂志,2005,21(1):23-25. 被引量:2
-
6万娟,李国华.NKG2D及其配体在消化系肿瘤中的研究进展[J].世界华人消化杂志,2009,17(31):3233-3236. 被引量:2
-
7叶萍,李燕,谷淑燕.MTS和MTT法检测小鼠NK及特异性细胞毒性T细胞活性的比较[J].中华实验和临床病毒学杂志,1998,12(1):85-86. 被引量:20
-
8黄海斌,杨文涛,王春凤,杨桂连.原虫抗肿瘤免疫机制研究进展[J].中国寄生虫学与寄生虫病杂志,2015,33(1):64-67. 被引量:5
-
9申露.幽门螺杆菌细胞毒素抑制T细胞活性[J].中华医学信息导报,2003,18(18):9-9.
-
10司同国,郭志,王海涛,刘长富,杨茂.冷冻联合GM-CSF治疗对前列腺癌小鼠脾脏树突状细胞免疫功能影响的实验观察[J].中华医学杂志,2011,91(17):1184-1187. 被引量:3